Analystreport

Esperion Therapeutics Inc (NASDAQ: ESPR) had its price target raised by analysts at JMP Securities to $191.00. They now have an "outperform" rating on the stock.

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com